Stock News

Agilent Technologies, Inc. -- Moody's: Agilent Technologies' acquisition of BioTek increases leverage, but adds complementary growth driver
Blue Lion To Sell Back All Its HomeStreet Shares
Agilent to acquire privately held BioTek instruments for $1.165 billion
Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment
Even Trade War Winners Can Lose. Just Ask Vietnam
5 Top & Flop ETF Areas of Q2
Agilent Technologies, Inc. -- Moody's announces completion of a periodic review of ratings of Agilent Technologies, Inc.
Agilent Introduces Breakthrough Flow Cytometer
New State of the Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics
Hedge Funds Are Buying Agilent Technologies Inc. (A)

As seen on...